Molecular predictors of anti-TNF treatment response in patients with Crohn's disease

被引：0
|
作者：
Walczak, M. [1 ]
Lykowska-Szuber, L. [2 ]
Plucinska, M. [3 ]
Michalak, M. [4 ]
Krela-Kazmierczak, I. [2 ]
Zakerska-Banaszak, O. [1 ]
Stawczyk-Eder, K. [2 ]
Eder, P. [2 ]
Dobrowolska, A. [2 ]
Slomski, R. [1 ]
Skrzypczak-Zielinska, M. [1 ]
机构：
[1] Polish Acad Sci, Inst Human Genet, Dept Nucle Acid Funct, Poznan, Poland
[2] Poznan Univ Med Sci, Dept Gastroenterol Dietet & Internal Dis, Poznan, Poland
[3] Adam Mickiewicz Univ, Inst Mol Biol & Biotechnol, Fac Biol, Dept Computat Biol, Poznan, Poland
[4] Poznan Univ Med Sci, Dept Comp Sci & Stat, Poznan, Poland
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P824
引用
收藏
页码：S640 / S640
页数：1
相关论文
共 50 条
  • [31] Rates of Anti-TNF Drug Persistence in Patients with Crohn's Disease
    Alexa, Silfen
    Tina, Rodriguez
    Jordan, Karpin
    Cindy, Traboulsi
    Victoria, Rai
    David, Rubin
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S9 - S9
  • [32] Efficacy of anti-TNFα drugs in patients with stricturing Crohn's disease
    D'Amico, Ferdinando
    Pugliese, Nicola
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (05) : 347 - 353
  • [33] Loss of response of anti-TNF in Crohn's disease patients single-centre experience
    Atanassova, A.
    Georgieva, A. C.
    Mirchev, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S434 - S434
  • [34] ENDOSCOPIC FINDINGS ARE USEFUL AS PREDICTORS OF EFFICACY OF ANTI-TNFα THERAPY FOR CROHN'S DISEASE
    Toyokawa, Tatsuya
    Horii, Joichiro
    Fujita, Isao
    [J]. GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB367 - AB367
  • [35] Endoscopic findings are useful as predictors of efficacy of anti-TNFα therapy for Crohn's disease
    Toyokawa, T.
    Horii, J.
    Fujita, I.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 112 - 112
  • [36] Loss of Anti-TNF Drugs Into Feces and Its Impact on Anti-TNF Serum Levels and Clinical Response in Crohn's Disease (CD) Patients
    Chaparro, Maria
    Guerra, Ivan
    Bujanda, Luis
    Nuno, Jose Luis Cabriada
    Taxonera, Carlos
    Marin-Jimenez, Ignacio
    Linares, Pablo M.
    Ramas, Mercedes
    Gisbert, Javier P.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S421 - S421
  • [37] In Vivo Molecular Imaging Using Fluorescent Anti-TNF Antibodies and Confocal Laser Endomicroscopy Predicts Response to Anti-TNF Therapy in Crohn's Disease
    Atreya, Raja
    Neumann, Helmut
    Neufert, Clemens
    Waldner, Maximilian J.
    Zopf, Yurdaguel
    Willma, Marcus
    App, Christine
    Muenster, Tino
    Kessler, Hermann
    Maas, Stefanie
    Gebhardt, Bernd
    Heimke-Brinck, Ralph
    Reuter, Eva
    Doerje, Frank
    Rau, Tilman T.
    Wang, Thomas D.
    Kiesslich, Ralf
    Vieth, Michael
    Hannappel, Ewald
    Neurath, Markus F.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S85 - S86
  • [38] Is treatment with a third anti-TNF agent a safe and effective option in patients with Crohn's disease?
    Franks I.
    [J]. Nature Reviews Gastroenterology & Hepatology, 2010, 7 (2) : 70 - 70
  • [39] Anti-TNF antibody approved for Crohn's disease
    不详
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (20) : 2073 - 2073
  • [40] Induction or Exacerbation of Psoriasis in Patients with Crohn's Disease under Treatment with Anti-TNF Antibodies
    Barthel, Christiane
    Biedermann, Luc
    Frei, Pascal
    Vavricka, Stephan R.
    Kuendig, Thomas
    Fried, Michael
    Rogler, Gerhard
    Scharl, Michael
    [J]. DIGESTION, 2014, 89 (03) : 209 - 215
12345